Category Medicine and Healthcare
Press Release
TODAY: Gb Sciences' President Demonstrates Effectiveness of Simplified Therapeutic Mixtures Inspired by Cannabis Plant Extracts at Canna Pharma 2022 Conference
Dr. Andrea Small-Howard discusses the company's novel process for developing disease-specific, cannabinoid-based therapeutics. Read More
Press Release
Group Dentistry Now and Seattle Study Club Enter Into a Strategic Agreement to Bring Continuing Education to DSOs and Emerging Dental Groups
The agreement brings together two industry leaders, leveraging complementary strengths to enhance support of doctors in building successful dental practices. This new education platform is called Group Dentistry Institute Powered by Seattle Study Club. Read More
Press Release
Ambit Inc. to Present Novel Projection Methodology for Rare Developmental and Epileptic Encephalopathies (DEEs) at the 2022 Child Neurology Society Annual Meeting
Ambit to showcase its prevalence projection approach, co-developed with Praxis, for rare developmental and epileptic encephalopathies (DEEs) as a Platform Presentation at this year's annual Child Neurology Society meeting Read More
Press Release
DroneSense Announces General Availability of Drone as First Responder Solution for Public Safety
This breakthrough technology allows public safety agencies to remotely operate and deploy drones in emergencies, giving first responders a real-time view of what is happening before they arrive at the scene. Read More
Press Release
ZetrOZ Systems' sam® Ultrasound Technology Expands Clinical Education on Sustained Acoustic Medicine
The wearable sustained acoustic medicine (sam®) treatment has been effectively utilized by sports medicine doctors, athletes and beyond to help rapidly treat tendon, ligament and other soft-tissue injuries. Read More
Press Release
Gb Sciences Co-Publishes Study Demonstrating Efficacy of Its Proprietary Cannabinoid Mixtures for the Treatment of Parkinson's Disease
As published in Frontiers in Pharmacology, the biopharmaceutical drug development firm's sponsored research has identified and validated cannabinoid ratio-controlled, Minimum Essential Mixtures (MEM) for the treatment of Parkinson's disease symptoms Read More
Press Release
BioNTech Establishes Asia-Pacific Clinical Scale mRNA Manufacturing & Regional Research Centre
German-based biotechnology company BioNTech will establish a clinical scale research mRNA manufacturing facility in Australia, following an in-principle letter of intent signed with the Victorian Government. Read More
Press Release
